New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy
Authors:
- Adrian H. TeruelATAdrian H. Teruel
- Isabel Gonzalez-AlvarezIsabel Gonzalez-Alvarez
- Marival BermejoMarival Bermejo
- Virginia MerinoVMVirginia Merino
- Maria Dolores MarcosMMMaria Dolores Marcos
- Felix SancenonFSFelix Sancenon
- Marta Gonzalez-AlvarezMGMarta Gonzalez-Alvarez
- Ramon Martinez-MañezRMRamon Martinez-Mañez
Open Access
- 5 September 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (18) , 6502
Abstract
Colonic Drug Delivery Systems (CDDS) are especially advantageous for local treatment of inflammatory bowel diseases (IBD). Site-targeted drug release allows to obtain a high drug concentration in injured tissues and less systemic adverse effects, as consequence of less/null drug absorption in small intestine. This review focused on the reported contributions in the last four years to improve the effectiveness of treatments of inflammatory bowel diseases. The work concludes that there has been an increase in the development of CDDS in which pH, specific enzymes, reactive oxygen species (ROS), or a combination of all of these triggers the release. These delivery systems demonstrated a therapeutic improvement with fewer adverse effects. Future perspectives to the treatment of this disease include the elucidation of molecular basis of IBD diseases in order to design more specific treatments, and the performance of more in vivo assays to validate the specificity and stability of the obtained systems.Keywords
This publication has 117 references indexed in Scilit:
- Small Intestinal Bacterial Overgrowth and Orocecal Transit Time in Patients of Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2013
- Effects of tempol and redox-cycling nitroxides in models of oxidative stressPharmacology & Therapeutics, 2010
- Colon Targeted Drug Delivery Systems: A Review on Primary and Novel ApproachesOman Medical Journal, 2010
- Inflammatory Bowel DiseaseAnnual Review of Immunology, 2010
- Therapeutic correction of bacterial dysbiosis discovered by molecular techniquesProceedings of the National Academy of Sciences, 2008
- American ginseng suppresses inflammation and DNA damage associated with mouse colitisCarcinogenesis, 2008
- New Directions in the Assessment of Gastric Function: Clinical Applications of Physiologic MeasurementsDigestive Diseases, 2006
- Very low intraluminal colonic pH in patients with active ulcerative colitisDigestive Diseases and Sciences, 1993
- Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.Gut, 1993
- The human intestinal microfloraDigestive Diseases and Sciences, 1986